Cargando…

Identification of undiagnosed dementia cases using a web‐based pre‐screening tool: The MOPEAD project

INTRODUCTION: Innovative patient engagement models are required to identify people with prodromal and mild Alzheimer's disease who are “hidden” in their communities and not normally found in a memory clinic setting. METHODS: A marketing campaign and a web‐based pre‐screening tool were used to i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodrigo, Adrián, Trigueros, Paloma, Jamilis, Laura, Alegret, Montserrat, Rodríguez, Octavio, Tárraga, Lluís, González‐Pérez, Antonio, Kramberger, Milica, Winblad, Bengt, Visser, Pieter Jelle, Jessen, Frank, Campo, Laura, Boada, Mercè
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Featured Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453736/ https://www.ncbi.nlm.nih.gov/pubmed/33860599 http://dx.doi.org/10.1002/alz.12297

Ejemplares similares

Complementary pre‐screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project
por: Boada, Mercè, et al.
Publicado: (2021)

A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer’s Disease: Results from the MOPEAD Project
por: Wimo, Anders, et al.
Publicado: (2021)

Clinical Applicability of the Specific Risk Score of Dementia in Type 2 Diabetes in the Identification of Patients with Early Cognitive Impairment: Results of the MOPEAD Study in Spain
por: Ortiz Zuñiga, Angel Michael, et al.
Publicado: (2020)

General practitioners’ attitude toward early and pre‐dementia diagnosis of AD in five European countries—A MOPEAD project survey
por: Sannemann, Lena, et al.
Publicado: (2021)

Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer’s Disease Research
por: Boada, Mercè, et al.
Publicado: (2018)

The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint
por: Jönsson, Linus, et al.
Publicado: (2023)

Neuropsychological, neuropsychiatric, and quality‐of‐life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study
por: Boada, Mercè, et al.
Publicado: (2021)

Cut-off Scores of a Brief Neuropsychological Battery (NBACE) for Spanish Individual Adults Older than 44 Years Old
por: Alegret, Montserrat, et al.
Publicado: (2013)

Correction: Cut-off Scores of a Brief Neuropsychological Battery (NBACE) for Spanish Individual Adults Older than 44 Years Old
por: Alegret, Montserrat, et al.
Publicado: (2014)

Plasma exchange for Alzheimer's disease Management by Albumin Replacement (AMBAR) trial: Study design and progress
por: Boada, Mercè, et al.
Publicado: (2019)

Personality Factors and Subjective Cognitive Decline: The FACEHBI Cohort
por: Muñoz, Nathalia, et al.
Publicado: (2020)

The effect of diagnostic criteria on outcome measures in preclinical and prodromal Alzheimer's disease: Implications for trial design
por: Bertens, Daniela, et al.
Publicado: (2017)

Cost of Diagnosing and Treating Cognitive Complaints: One-year Cost-evaluation Study in a Patient Cohort from a Slovenian Memory Clinic
por: Županič, Eva, et al.
Publicado: (2022)

A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study
por: Boada, Mercè, et al.
Publicado: (2020)

Perception of Risk of Developing Diabetes Among Patients With Undiagnosed Prediabetes: The Impact of Health Care Provider Advice
por: Mainous, Arch G., et al.
Publicado: (2019)

Social Representation of Dementia: An Analysis of 5,792 Consecutive Cases Evaluated in a Memory Clinic
por: Cañabate, Pilar, et al.
Publicado: (2017)

The worldwide costs of dementia 2015 and comparisons with 2010
por: Wimo, Anders, et al.
Publicado: (2017)

Time from diagnosis to institutionalization and death in people with dementia
por: Joling, Karlijn J., et al.
Publicado: (2020)

Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer’s Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial
por: Boada, Mercè, et al.
Publicado: (2017)

The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriers
por: Sánchez-Juan, Pascual, et al.
Publicado: (2019)

Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis of Critical Covariates
por: Ruiz, Agustín, et al.
Publicado: (2013)

Correction: Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis of Critical Covariates
por: Ruiz, Agustín, et al.
Publicado: (2014)

Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer’s disease patients
por: Kirsebom, Bjørn Eivind, et al.
Publicado: (2022)

Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study
por: Lopes Alves, Isadora, et al.
Publicado: (2020)

Transformational Leadership Meets Innovative Strategy: How Nurse Leaders and Clinical Nurses Redesigned Bedside Handover to Improve Nursing Practice
por: Brown-Deveaux, Dewi, et al.
Publicado: (2022)

FFP3 respirator face fit testing - what is it all about?
por: Rollings, Laura
Publicado: (2020)

'From a dental point of view, we must keep smiling'
por: Marshall, Laura
Publicado: (2020)

Ethnicity and working within dentistry
por: Hinds, Laura
Publicado: (2021)

What if funding wasn't an issue?
por: Marshall, Laura
Publicado: (2021)

Dynamic Classes and Eager Students
por: Carruth, Laura L.
Publicado: (2012)

Recent Developments in Alcohol Services Research on Access to Care
por: Schmidt, Laura A.
Publicado: (2016)

The Role of Innate Immunity in Alcoholic Liver Disease
por: Nagy, Laura E.
Publicado: (2015)

Laura Carruth
por: Hoopes, Laura L. Mays
Publicado: (2010)

Maritza Macdonald
por: Mays Hoopes, Laura L.
Publicado: (2010)

E. Virginia Armbrust
por: Hoopes, Laura L. Mays
Publicado: (2010)

Robert Full
por: Hoopes, Laura L. Mays
Publicado: (2010)

Proactive Strategy to Improve Staff Engagement
por: George, Viji, et al.
Publicado: (2020)

'I have been able to reconnect with my patients'
por: Alhelou, Noor, et al.
Publicado: (2020)

Characteristics of subjective cognitive decline associated with amyloid positivity
por: Janssen, Olin, et al.
Publicado: (2021)

COVID-19-Mediated Strengths and Challenges for 2021 Nursing Graduates: Implications for Nurse Leaders and Educators
por: Dzurec, Laura, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6ctmqogq8l52kqok6g9vhg9g7i